Sentinel Lymph Node Clinical Trial
Official title:
Analysis of the Cost of Using FLUOrescence in Green of Indocyanine for the Detection of the Sentinel Lymph Node in the Breast Cancer.
The purpose of this study is to analyze the average direct costs of each of these techniques, represented by the costs directly linked to the management of breast cancer, to the surgical intervention and to the techniques evaluated (Indocyanine Green and isotopes) which are: consultations, hospitalizations, resources consumed during the surgical intervention, as well as the time of the patients, transport...
The main objective is to evaluate the overall cost at 1 month of the sentinel lymph node detection technique using Indocyanine Green compared to the technique using isotopes in patients with breast cancer, from the point of view of health insurance and the hospital. The chosen time horizon is up to 1 month post-intervention. The choice of this time horizon corresponds to the usual duration of follow-up for patients who have benefited from one of the sentinel lymph node detection techniques, in order to collect the main post-surgical complications. This is a multicenter, prospective, observational, non-randomized study, aimed at comparing the overall cost of two sentinel lymph node detection techniques (Indocyanine Green and isotope) from a dual perspective (health insurance and hospital). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05437380 -
Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC
|
N/A | |
| Active, not recruiting |
NCT04303715 -
No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography
|
N/A | |
| Completed |
NCT05498051 -
Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.
|
N/A | |
| Active, not recruiting |
NCT06169787 -
Sentinel Lymph Nodes Biopsy in Cervical Cancer
|
||
| Completed |
NCT03294330 -
SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast Cancer
|
Phase 3 | |
| Not yet recruiting |
NCT04930692 -
A Prospective Single-center Cohort Study "Preoperative Identification of Sentinel Lymph Nodes Using Contrast-enhanced CT Lymphography in Breast Cancer Patients"
|
N/A | |
| Recruiting |
NCT03749707 -
HPV in Sentinel Lymph Nodes
|
N/A | |
| Completed |
NCT03899441 -
Multimedia Aid Gynecologic Counseling and Consent
|
N/A | |
| Recruiting |
NCT04826211 -
Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI
|
N/A | |
| Not yet recruiting |
NCT06130241 -
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?
|
N/A | |
| Recruiting |
NCT04664582 -
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
|
N/A | |
| Withdrawn |
NCT04487912 -
Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer
|
Phase 4 | |
| Completed |
NCT03563781 -
SEntine Lymph Node in earLY Ovarian Cancer (SELLY)
|
N/A | |
| Recruiting |
NCT05623280 -
Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.
|
||
| Active, not recruiting |
NCT05359783 -
Sentinel Node Localization and Staging With Low Dose Superparamagnetic Iron Oxide
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT04568941 -
Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer
|
N/A | |
| Completed |
NCT03606616 -
Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients
|
||
| Recruiting |
NCT02982148 -
Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients
|
Phase 4 | |
| Recruiting |
NCT06161428 -
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer
|
||
| Completed |
NCT03900104 -
Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer
|
N/A |